These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38491962)

  • 61. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
    Mühlbacher AC; Nübling M
    Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantifying stakeholders' preference for implantable medical devices in China: a discrete choice experiment.
    Wan B; Shen J; Chen J; Weng L; Zhao P; Deng Y; Zhang L; Zhang F; Wang Y; Li X; Chang F; Ding H; Lu Y
    Int J Technol Assess Health Care; 2024 Jan; 40(1):e8. PubMed ID: 38221900
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
    Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
    Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis.
    Shingler SL; Swinburn P; Ali S; Perard R; Lloyd AJ
    J Med Econ; 2013 Aug; 16(8):1036-42. PubMed ID: 23730944
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Choosing vs. allocating: discrete choice experiments and constant-sum paired comparisons for the elicitation of societal preferences.
    Skedgel CD; Wailoo AJ; Akehurst RL
    Health Expect; 2015 Oct; 18(5):1227-40. PubMed ID: 23758539
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
    Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
    Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 68. Using Discrete Choice Experiments to Quantify Patient Preferences.
    O'Hara NN; Sciadini MF
    J Am Acad Orthop Surg; 2024 Jan; 32(1):e9-e16. PubMed ID: 37647520
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mobilising the Next Generation of Stated-Preference Studies: the Association of Access Device with Choice Behaviour and Data Quality.
    Vass CM; Boeri M
    Patient; 2021 Jan; 14(1):55-63. PubMed ID: 33355916
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
    Qian Y; Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Hechmati G; Gatta F; Harrelson S; Campbell-Baird C
    Patient; 2016 Aug; 9(4):323-33. PubMed ID: 26821359
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discrete choice analysis of health worker job preferences in Ethiopia: Separating attribute non-attendance from taste heterogeneity.
    Arora N; Quaife M; Hanson K; Lagarde M; Woldesenbet D; Seifu A; Crastes Dit Sourd R
    Health Econ; 2022 May; 31(5):806-819. PubMed ID: 35178825
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis.
    DiSantostefano RL; Simons G; Englbrecht M; Humphreys JH; Bruce IN; Bywall KS; Radawski C; Raza K; Falahee M; Veldwijk J
    Med Decis Making; 2024 Feb; 44(2):189-202. PubMed ID: 38240281
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Physicians' preferences for prescribing oral and intravenous anticancer drugs: a Discrete Choice Experiment.
    Benjamin L; Cotté FE; Philippe C; Mercier F; Bachelot T; Vidal-Trécan G
    Eur J Cancer; 2012 Apr; 48(6):912-20. PubMed ID: 22033327
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patient preferences for diabetes treatment attributes and drug classes.
    Flood EM; Bell KF; de la Cruz MC; Ginchereau-Sowell FM
    Curr Med Res Opin; 2017 Feb; 33(2):261-268. PubMed ID: 27779433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 78. What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment.
    Ho KA; Acar M; Puig A; Hutas G; Fifer S
    Clin Rheumatol; 2020 Apr; 39(4):1077-1089. PubMed ID: 31858340
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A discrete-choice experiment to assess treatment modality preferences of patients with anxiety disorder.
    Lokkerbol J; van Voorthuijsen JM; Geomini A; Tiemens B; van Straten A; Smit F; Risseeuw A; van Balkom A; Hiligsmann M
    J Med Econ; 2019 Feb; 22(2):169-177. PubMed ID: 30501135
    [TBL] [Abstract][Full Text] [Related]  

  • 80. U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment.
    Graham SM; Barthold D; Hauber B; Brah AT; Saldarriaga E; Collier AC; Ho RJY; ; Marconi VC; Simoni JM
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26099. PubMed ID: 37439051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.